125 related articles for article (PubMed ID: 37077062)
1. Relationship of E-cadherin, Beta-catenin, N-cadherin, ZEB1 and αSMA as Epithelial Mesenchymal Transition markers with prognostic factors in early and advanced stage laryngeal squamous cell carcinomas.
Kucuk U; Ekmekci S; Talu CK; Pekcevik Y; Cukurova I
Indian J Pathol Microbiol; 2023; 66(2):237-245. PubMed ID: 37077062
[TBL] [Abstract][Full Text] [Related]
2. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Auris Nasus Larynx; 2021 Dec; 48(6):1167-1175. PubMed ID: 34001394
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Medicine (Baltimore); 2021 Mar; 100(12):e25028. PubMed ID: 33761659
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
6. Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma.
Zhu GJ; Song PP; Zhou H; Shen XH; Wang JG; Ma XF; Gu YJ; Liu DD; Feng AN; Qian XY; Gao X
Oncol Lett; 2018 Mar; 15(3):3472-3481. PubMed ID: 29467869
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma.
Cappellesso R; Marioni G; Crescenzi M; Giacomelli L; Guzzardo V; Mussato A; Staffieri A; Martini A; Blandamura S; Fassina A
Histopathology; 2015 Oct; 67(4):491-500. PubMed ID: 25684546
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of E-cadherin and β-catenin overexpression in laryngeal squamous cell carcinoma.
Greco A; De Virgilio A; Rizzo MI; Pandolfi F; Rosati D; de Vincentiis M
Laryngoscope; 2016 Apr; 126(4):E148-55. PubMed ID: 26511677
[TBL] [Abstract][Full Text] [Related]
10. β-Arrestin-1 expression and epithelial-to-mesenchymal transition in laryngeal carcinoma.
Marioni G; Nicolè L; Cappellesso R; Marchese-Ragona R; Fasanaro E; Di Carlo R; La Torre FB; Nardello E; Sanavia T; Ottaviano G; Fassina A
Int J Biol Markers; 2019 Mar; 34(1):33-40. PubMed ID: 30854928
[TBL] [Abstract][Full Text] [Related]
11. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer.
Matsubara D; Kishaba Y; Yoshimoto T; Sakuma Y; Sakatani T; Tamura T; Endo S; Sugiyama Y; Murakami Y; Niki T
Pathol Int; 2014 Nov; 64(11):560-8. PubMed ID: 25347933
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression.
Horny K; Sproll C; Peiffer L; Furtmann F; Gerhardt P; Gravemeyer J; Stoecklein NH; Spassova I; Becker JC
J Transl Med; 2023 Apr; 21(1):267. PubMed ID: 37076857
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Epithelial-Mesenchymal Transition Markers "E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63" in Bladder Carcinoma.
Moussa RA; Khalil EZI; Ali AI
World J Oncol; 2019 Dec; 10(6):199-217. PubMed ID: 31921376
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A
Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477
[TBL] [Abstract][Full Text] [Related]
16. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
18. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
19. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
[TBL] [Abstract][Full Text] [Related]
20. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
